D
Ionis Pharmaceuticals, Inc. IONS
$43.03 $0.050.12% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 286.45% -2.90% -1,026.51% 4.70% 22.31%
Total Depreciation and Amortization -2.24% -4.49% -6.15% -1.75% -1.93%
Total Amortization of Deferred Charges -1.50% -1.50% 0.60% -1.29% 12.91%
Total Other Non-Cash Items 48.28% -2.47% 95.07% -23.00% 169.14%
Change in Net Operating Assets 69.71% 9.55% -572.70% -129.99% -197.89%
Cash from Operations 226.24% -0.56% -453.38% -5.47% -23.13%
Capital Expenditure -97.39% -179.92% -3,213.19% -322.98% 48.10%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -256.90% 127.10% 440.37% -568.21% -15.75%
Cash from Investing -292.26% 123.98% 355.36% -595.98% -10.16%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -2.56% -7.69% -117,123.68% 99.93% 99.99%
Issuance of Common Stock -50.42% -90.51% -98.95% 13,200.13% 8.62%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -51.23% -90.67% -208.33% 1,637.32% -98.22%
Foreign Exchange rate Adjustments 2,686.96% 303.51% -247.27% 330.26% -132.86%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 160.32% 143.90% -296.01% 155.84% -147.42%